STEMLINE THERAPEUTICS INC — Form D
STEMLINE THERAPEUTICS INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-01-17. $740K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-01-17
- Form: D
- Accession: 0000908662-12-000005
- Industry: Pharmaceuticals
- Exemptions: 06
- Amount sold: $740K
- Investors: 16
- Date of first sale: 2012-01-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-172007
Issuer
- Name: STEMLINE THERAPEUTICS INC
- CIK: 0001264587
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1675 YORK AVENUE, SUITE 34-L, NEW YORK, NY, 10128
- Phone: 212-531-5969
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ronald Bentsur | Director | New York, NY |
| Ivan Bergstein, M.D. | Director | New York, NY |
| Ivan Bergstein, M.D. | Executive Officer | New York, NY |
| Ivan Bergstein | Director | New York, NY |
| Ivan Bergstein | Executive Officer | New York, NY |
Other filings by this issuer (2)
More